Ovid Therapeutics
1.60
+0.15
+10.34%
OVID
02-06 16:00:00(美东时间)
高
1.61
开
1.45
量
157.88万股
总市值
2.08亿
低
1.45
换
1.21%
额
244.02万
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
Ovid Therapeutics(OVID)
01-30 09:05
$Ovid Therapeutics(OVID)$
SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001315863-26-000096 Act: 34 Size: 14 KB
网页链接
Ovid Therapeutics(OVID)
01-09 01:05
$Ovid Therapeutics(OVID)$
SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001623632-26-000052 Act: 34 Size: 45 KB
网页链接
Ovid Therapeutics(OVID)
01-06 07:05
$Ovid Therapeutics(OVID)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0002036798-26-000002 Size: 5 KB
网页链接
Ovid Therapeutics(OVID)
01-06 05:15
$Ovid Therapeutics(OVID)$
SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-26-000036 Act: 34 Size: 18 KB
网页链接
Ovid Therapeutics(OVID)
2025-12-23 19:05
$Ovid Therapeutics(OVID)$
EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003891 Act: 33 Size: 1 KB
网页链接
Ovid Therapeutics(OVID)
2025-12-23 05:35
$Ovid Therapeutics(OVID)$
424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001193125-25-328805 Act: 33 Size: 184 KB
网页链接
Ovid Therapeutics(OVID)
2025-12-19 07:15
$Ovid Therapeutics(OVID)$
SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001346824-25-000079 Act: 34 Size: 19 KB
网页链接
Ovid Therapeutics(OVID)
2025-12-19 05:25
$Ovid Therapeutics(OVID)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001256153-25-000004 Size: 15 KB
网页链接
Ovid Therapeutics(OVID)
2025-12-19 05:15
$Ovid Therapeutics(OVID)$
SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001315863-25-000859 Act: 34 Size: 13 KB
网页链接
Ovid Therapeutics(OVID)
2025-12-18 21:45
$Ovid Therapeutics(OVID)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-323798 Act: 34 Size: 174 KB
网页链接
Ovid Therapeutics(OVID)
2025-12-16 06:35
$Ovid Therapeutics(OVID)$
S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-25-319453 Act: 33 Size: 416 KB
网页链接
Ovid Therapeutics(OVID)
2025-12-12 03:05
$Ovid Therapeutics(OVID)$
8-K Current report, item 5.07 Accession Number: 0001636651-25-000017 Act: 34 Size: 154 KB
网页链接
Ovid Therapeutics(OVID)
2025-12-10 10:25
$Ovid Therapeutics(OVID)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001395064-25-000172 Size: 10 KB
网页链接
Ovid Therapeutics(OVID)
2025-12-10 10:05
$Ovid Therapeutics(OVID)$
SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001395064-25-000167 Act: 34 Size: 20 KB
网页链接
Ovid Therapeutics(OVID)
2025-12-09 00:55
$Ovid Therapeutics(OVID)$
SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001274173-25-000340 Act: 34 Size: 9 KB
网页链接
Ovid Therapeutics(OVID)
2025-11-12 20:15
$Ovid Therapeutics(OVID)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001636651-25-000012 Act: 34 Size: 7 MB
网页链接
Ovid Therapeutics(OVID)
2025-11-12 20:05
$Ovid Therapeutics(OVID)$
8-K Current report, items 2.02, 5.02, and 9.01 Accession Number: 0001636651-25-000011 Act: 34 Size: 267 KB
网页链接
Ovid Therapeutics(OVID)
2025-11-07 19:15
$Ovid Therapeutics(OVID)$
DEF 14A Other definitive proxy statements Accession Number: 0001140361-25-040884 Act: 34 Size: 1 MB
网页链接
Ovid Therapeutics(OVID)
2025-10-28 18:05
$Ovid Therapeutics(OVID)$
PRE 14A Other preliminary proxy statements Accession Number: 0001140361-25-039516 Act: 34 Size: 1 MB
网页链接
Ovid Therapeutics(OVID)
2025-10-28 05:35
$Ovid Therapeutics(OVID)$
PREM14A Preliminary proxy statements relating to merger or acquisition Accession Number: 0001140361-25-039497 Act: 34 Size: 1 MB
网页链接